Internal Medicine, Endocrinology, Diabetes, & Metabolism · Marietta, GA
NPI
1669462990
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
625 Church Street NW
Marietta, GA, 30060
Phone (770) 422-2004
Groups this clinician bills Medicare through
Medicare paid, 2024
$82K
2,219 services
Medicare patients, 2024
443
Average age 74
Drug cost, 2024
$2.3M
6,003 prescriptions
Company payments, 2025
$651
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nitin N Mayur was code 99214 (office e&m - established), 518 times for 328 patients. In total Nitin N Mayur billed 2,219 services in 17 codes, and Medicare paid $82K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-10-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 518 | 328 | $90.34 | $47K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 473 | 318 | $11.85 | $5,606 |
| 83036 Blood Count | Office | 293 | 171 | $9.52 | $2,789 |
| 99213 Office E&M - Established | Office | 234 | 190 | $63.63 | $15K |
| 95251 Test - Miscellaneous | Office | 125 | 69 | $26.10 | $3,263 |
| 76536 Ultrasound - Nonspecific | Office | 62 | 61 | $73.48 | $4,556 |
| 82962 Clinical Chemistry | Office | 38 | 33 | $3.21 | $122 |
| 99204 Office E&M - New | Office | 19 | 19 | $104.16 | $1,979 |
By year: 2022 $80K for 1,734 services; 2023 $79K for 1,482 services; 2024 $82K for 2,219 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 293 | 171 | $9.52 | $2,789 |
| 82962 Clinical Chemistry | 38 | 33 | $3.21 | $122 |
Medicare prescription drug claims, 2024
In 2024, the drug Nitin N Mayur prescribed most often to Medicare patients was Levothyroxine Sodium, with 946 prescriptions and refills. In total Nitin N Mayur wrote 6,003 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 946 | 2,590 | 261 | $12K |
| Ozempic Semaglutide | 374 | 605 | 72 | $575K |
| Metformin Hcl Generic | 316 | 903 | 101 | $2,779 |
| Jardiance Empagliflozin | 217 | 462 | 56 | $264K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 217 | 542 | 61 | $35K |
| Synthroid Levothyroxine Sodium | 160 | 412 | 46 | $14K |
| Novolog Flexpen Insulin Aspart | 150 | 339 | 57 | $65K |
| Atorvastatin Calcium Generic | 128 | 362 | 40 | $1,245 |
| Mounjaro Tirzepatide | 124 | 153 | 21 | $159K |
| Glipizide Generic | 121 | 328 | 41 | $1,373 |
| Metformin Hcl Er Metformin Hcl | 114 | 319 | 39 | $1,108 |
| Farxiga Dapagliflozin Propanediol | 114 | 226 | 24 | $123K |
| Glimepiride Generic | 114 | 289 | 31 | $1,189 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 108 | 286 | 46 | $15K |
| Glipizide Er Glipizide | 101 | 290 | 29 | $1,812 |
Brand drugs: 3,128 claims; generic drugs: 2,491 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nitin N Mayur $651 ($651 in general payments such as food, travel and fees) from 13 companies. The largest payer was Abbott Laboratories with $146.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 10 | $146 |
| CeQur Corporation | 1 | $84.49 |
| Novo Nordisk Inc NVO | 3 | $69.9 |
| Amgen Inc. AMGN | 3 | $69.54 |
| Sequel Med Tech, LLC | 3 | $58.87 |
| Neurocrine BioSciences, Inc. NBIX | 2 | $53.21 |
| Lilly USA, LLC LLY | 2 | $41.53 |
| IBSA Pharma Inc. | 2 | $37.32 |
| Beta Bionics, Inc. BBNX | 1 | $24.81 |
| Ascensia Diabetes Care Us Inc. | 1 | $18.74 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.